Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Colorcon
Boehringer Ingelheim
Dow
AstraZeneca

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Histidine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Histidine: Patents, clinical trial progress, indications

Histidine is an investigational drug.

There have been 23 clinical trials for Histidine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Malaria, Falciparum, Macular Edema, and Malaria. The leading clinical trial sponsors are China Medical University Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Cardiovascular Center Harapan Kita Hospital Indonesia.

There are two US patents protecting this investigational drug and forty-five international patents.

Recent Clinical Trials for Histidine
TitleSponsorPhase
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionMalaria Research and Training Center, Bamako, MaliPhase 4
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionRadboud UniversityPhase 4
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionLondon School of Hygiene and Tropical MedicinePhase 4

See all Histidine clinical trials

Clinical Trial Summary for Histidine

Top disease conditions for Histidine
Top clinical trial sponsors for Histidine

See all Histidine clinical trials

US Patents for Histidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Histidine   See Pricing Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE)   See Pricing
Histidine   See Pricing Steviol glucosyltransferases and genes encoding the same SUNTORY HOLDINGS LIMITED (Osaka, JP)   See Pricing
Histidine   See Pricing Fibrinogen preparations enriched in fibrinogen with an extended alpha chain Mallinckrodt Pharma IP Trading D.A.C. (Dublin, IE)   See Pricing
Histidine   See Pricing Compositions and methods for inhibition of the JAK pathway Rigel Pharmaceuticals, Inc. (South San Francisco, CA)   See Pricing
Histidine   See Pricing Compounds that bind to the erythropoietin receptor   See Pricing
Histidine   See Pricing Recombinant yeast having enhanced gamma valerolactone tolerance and methods of use Wisconsin Alumni Research Foundation (Madison, WI)   See Pricing
Histidine   See Pricing Recombinant host cells comprising phosphoketalase Butamax Advanced Biofuels LLC (Wilmington, DE)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Histidine

Drugname Country Document Number Estimated Expiration Related US Patent
Histidine Argentina 100926 2034-06-20   See Pricing
Histidine Canada 2950827 2034-06-20   See Pricing
Histidine European Patent Office 3157549 2034-06-20   See Pricing
Histidine United Kingdom 201411037 2034-06-20   See Pricing
Histidine Japan 2017525336 2034-06-20   See Pricing
Histidine Japan 6560261 2034-06-20   See Pricing
Histidine Taiwan 201613956 2034-06-20   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
Baxter
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.